Research News

• Do Peptides Work for Looksmaxxing? Science vs. Hype

  Looksmaxxing peptides are the internet's newest shortcut — but the evidence doesn't back the hype. What researchers and doctors say about BPC-157 and GHK-Cu.

  Aug 23, 2026

• Aleniglipron: The New Oral GLP-1 Pill With 12.1% Weight Loss at 36 Weeks

  Aleniglipron (GSBR-1290) delivered 12.1% weight loss at 36 weeks in the Phase 2b ACCESS trial. Is it FDA approved? Compare it to the Wegovy pill and Foundayo.

  Aug 23, 2026

• Oral GLP-1 Comparison 2026: Aleniglipron vs Wegovy Pill vs Foundayo

  Oral GLP-1 pills compared: aleniglipron 12.1% at 36 weeks, Wegovy pill, Foundayo, Rybelsus, elecoglipron — efficacy, dosing, food rules, FDA status.

  Aug 23, 2026

• What Is TOFA? Fat Loss Without Muscle Loss (2026)

  TOFA burned fat without muscle loss in a new Science Advances mouse study — and boosted GLP-1 results. Here's what the 2026 evidence actually shows.

  Aug 23, 2026

• BPC-157 Human Trials: What the 2026 Evidence Actually Shows

  BPC-157 has decades of animal research but a thin human evidence base. A new Phase 2 hamstring trial and the clinical landscape in 2026, explained.

  Aug 22, 2026

• Does GLP-1 Reduce Belly Fat? 2026 Evidence on Visceral Fat

  Does GLP-1 reduce belly fat? We break down the 2026 trial data on visceral fat loss, waist reduction, and heart-health benefits, with realistic timelines.

  Aug 15, 2026

• Peptides, Explained: What the Science Says vs. What the Hype Claims

  Peptides are the hottest wellness trend — but what does the science actually say? Stanford experts on BRP, the evidence gap, and what's FDA-approved.

  Aug 11, 2026

• AI Designs Better Peptide Antibiotics in Landmark UPenn Study

  ApexGO, a new Penn AI system, designed antibiotic peptides that halted 85% of bacterial growth in lab tests and outperformed existing candidates.

  May 13, 2026

• PubMed Digest — May 2026: BPC-157, MOTS-c, LL-37 Research Updates

  Recent peer-reviewed publications on BPC-157, MOTS-c, GHK-Cu, Epitalon, and LL-37 — systematic reviews, mechanistic studies, and antimicrobial advances.

  May 7, 2026

• BPC-157: What the Research Actually Shows (And What It Doesn't)

  BPC-157 has the strongest practitioner reputation of the reclassified peptides. An honest read on preclinical breadth, human trial gaps, and what it means.

  Apr 27, 2026